Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Torrens

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 3, 2024
Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacaeIsabel M Barceló, María Escobar-Salom, Elena Jordana-Lluch, et al.
Molecules (Basel, Switzerland)|August 22, 2017
Synthesis and Antimicrobial Studies of New Antibacterial Azo-Compounds Active against Staphylococcus aureus and Listeria monocytogenesStefano Piotto, Simona Concilio, Lucia Sessa, et al.
Msystems|December 5, 2019
Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different SignalingGabriel Torrens, Sara Belén Hernández, Juan Alfonso Ayala, et al.
The Journal of Infectious Diseases|July 21, 2019
In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting ImmunityGabriel Torrens, Irina Sánchez-Diener, Elena Jordana-Lluch, et al.
Microbiology Spectrum|July 30, 2025
An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β-lactam resistance in <i>Pseudomonas aeruginosa</i>Maria Escobar-Salom, Isabel M Barceló, Jordi Sansó-Sastre, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance MechanismsGabriel Torrens, Gabriel Cabot, Alain A Ocampo-Sosa, et al.
Frontiers in Microbiology|September 12, 2019
Comparative Analysis of Peptidoglycans From <i>Pseudomonas aeruginosa</i> Isolates Recovered From Chronic and Acute InfectionsGabriel Torrens, María Escobar-Salom, Elisabet Pol-Pol, et al.
Plos One|July 26, 2017
Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune systemGabriel Torrens, Marcelo Pérez-Gallego, Bartolomé Moya, et al.
Molecular Biology of the Cell|May 15, 2025
Activation of the ChvG-ChvI pathway promotes survival during cell wall stress in <i>Agrobacterium tumefaciens</i>Jacob M Bouchier, Emily Knebel, Jennifer Amstutz, et al.
Microbiology Spectrum|October 10, 2022
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosaIsabel M Barceló, Elena Jordana-Lluch, María Escobar-Salom, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 3, 2024
Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacaeIsabel M Barceló, María Escobar-Salom, Elena Jordana-Lluch, et al.
Molecules (Basel, Switzerland)|August 22, 2017
Synthesis and Antimicrobial Studies of New Antibacterial Azo-Compounds Active against Staphylococcus aureus and Listeria monocytogenesStefano Piotto, Simona Concilio, Lucia Sessa, et al.
Msystems|December 5, 2019
Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different SignalingGabriel Torrens, Sara Belén Hernández, Juan Alfonso Ayala, et al.
The Journal of Infectious Diseases|July 21, 2019
In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting ImmunityGabriel Torrens, Irina Sánchez-Diener, Elena Jordana-Lluch, et al.
Microbiology Spectrum|July 30, 2025
An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β-lactam resistance in <i>Pseudomonas aeruginosa</i>Maria Escobar-Salom, Isabel M Barceló, Jordi Sansó-Sastre, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance MechanismsGabriel Torrens, Gabriel Cabot, Alain A Ocampo-Sosa, et al.
Frontiers in Microbiology|September 12, 2019
Comparative Analysis of Peptidoglycans From <i>Pseudomonas aeruginosa</i> Isolates Recovered From Chronic and Acute InfectionsGabriel Torrens, María Escobar-Salom, Elisabet Pol-Pol, et al.
Plos One|July 26, 2017
Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune systemGabriel Torrens, Marcelo Pérez-Gallego, Bartolomé Moya, et al.
Molecular Biology of the Cell|May 15, 2025
Activation of the ChvG-ChvI pathway promotes survival during cell wall stress in <i>Agrobacterium tumefaciens</i>Jacob M Bouchier, Emily Knebel, Jennifer Amstutz, et al.
Microbiology Spectrum|October 10, 2022
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosaIsabel M Barceló, Elena Jordana-Lluch, María Escobar-Salom, et al.
Pageof 4